Evaluating the Immunogenicity of the AIDSVAX B/E Vaccine and the MVA/HIV62B Vaccine in Healthy, HIV-1-Uninfected Adults Who Previously Received MVA/HIV62B in DNA/MVA or MVA/MVA Regimens in HVTN 205
Clinical trial NCT02852005 · COMPLETED
Trial details
- NCT number
- NCT02852005
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2018-08-29
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.